The American Hospital Association has called on federal regulators to intervene after Eli Lilly sent warning letters to 340B hospitals threatening to cut off discounted drug pricing unless they submit ...
The AHA again is asking the Health Resources and Services Administration to take action after Eli Lilly warned hospitals that ...
The American Hospital Association (AHA) writes to alert you to the latest development in connection with the growing number ...
A new chapter in the 340B Drug Pricing Program is unfolding as the Health Resources & Services Administration (“HRSA”) pursues its 340B Rebate Model Pilot Program (the “Pilot Program”)—a move ...
The Health Resources and Services Administration (HRSA) issued a notice announcing the application process for the 340B rebate model pilot program and requesting public comment. The notice sets the ...
HRSA is piloting a 340B rebate model similar to one that it just fought against. As the agency dips its toes into the 340B debate, hospital groups express concerns about the potential for cash flow ...
Hospitals and clinics told regulators that switching to rebates in the 340B drug discount program would impose costs that ...
Hospital and pharma groups have sharpened their spears for the rematch on 340B rebates.  | The administration's second stab ...
Add Yahoo as a preferred source to see more of our stories on Google. This story was originally published on Healthcare Dive. To receive daily news and insights, subscribe to our free daily Healthcare ...
In February 2026, the Department of Justice filed amicus briefs supporting pharmaceutical manufacturers, asserting that Rhode ...
The anticipated burdens on hospitals to comply with the Health Resources and Services Administration's 340B Rebate Pilot Program far exceed the agency's estimates, and HRSA should delay the program's ...
We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...